Indico to Sponsor AI Pharma Innovation Clinical Development

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
49
Indico to Sponsor AI Pharma Innovation Clinical Development Summit

BOSTON, July 18, 2018 (GLOBE NEWSWIRE) -- Indico , a provider of enterprise AI solutions for unstructured content, will be a featured event partner at the 2018 AI Pharma Innovation Clinical Development Summit taking place July 24-26 in Boston at the Revere Hotel. Other event sponsors include Applied Informatics, Enlitic and Medidata. 

The Summit is part of the AI Pharma Innovation Series, a set of conferences dedicated to accelerating the effective adoption and application of AI and machine learning at specific points in the pharmaceutical value chain. This event brings together leading scientists, technology developers, and decision makers in the pharmaceutical and biotechnology industries to discover how to harness AI to enhance trial design, improve patient selection, identify biomarkers for precision medicine development and optimize pharmacovigilance studies.

Indico is helping Pharma companies leverage AI and machine learning to streamline the preparation of and increase the accuracy and regulatory compliance of clinical research that typically involves large amounts of unstructured, document-based content.  

“The clinical research process is still driven by a huge variety of manual workflows designed to address patient recruitment and retention, pharmacovigilance, and site selection,” said Indico CEO Tom Wilde. “The ability to apply AI to augment and automate document-intensive workflows is a game changer for the industry and Indico is uniquely positioned to solve these challenges.”

About Indico Indico is an enterprise AI solution for unstructured content. Our focus is on helping to automate tedious back-office tasks, improving the efficiency of labor-intensive document-based workflows, and extracting valuable insights from unstructured content, including text and images. Our breakthrough in solving these challenges is an approach known as transfer learning, which allows us to train machine learning models with orders of magnitude less data than required by traditional content analysis techniques. With Indico, enterprises are now able to benefit from the dramatic advantages of machine learning at a fraction of the time. For more information, visit. https://indico.io/ .

Media Contact: Tim Walsh, for Indico 617.512.1641

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Exploring Advances in AI and Digital R&D Innovation by ICON plc

Updated Category News Views 227

Recent Developments in AI and Digital Innovation by ICON plc ICON plc, a globally recognized clinical research organization (NASDAQ: ICLR), has recently conducted an extensive survey exploring the integration of Artificial Intelligence (AI) and digital tools within clinical research. Engaging with over 100 professionals in the biotech and pharmaceutical industries across...

Continue Reading
Tesla's Self-Driving Claims Under Fire: Industry Reactions

Updated Category News Views 167

Tesla's License Suspension in California Recently, a court in California announced a significant development affecting Tesla Inc. (NASDAQ: TSLA). The court decided to suspend Tesla's license to sell vehicles for 30 days due to a lawsuit concerning misleading claims about the company's Full Self-Driving (FSD) technology. If Tesla does not adapt its policies within 90 days,...

Continue Reading
Sunnova Energy Faces Challenges Amid Revenue Declines in 2024

Updated Category News Views 384

Sunnova Energy Experiences Financial Struggles Sunnova Energy International Inc. (NOVA) has encountered a challenging period, with its shares trading lower in the premarket on Monday following a disappointing report detailing its fourth quarter and full-year financial results. The financial landscape for Sunnova shows a revenue of $224.127 million, which unfortunately...

Continue Reading
Kerusso's Important Contributions in Faith and Community Work

Updated Category News Views 133

Kerusso's Inspiring Charitable Contributions in 2025 Kerusso Activewear, a prominent Christian apparel and gift brand, has ended the year with a remarkable achievement of over $400,000 in charitable contributions. This reflects their steadfast commitment to enriching lives through faith-based approaches and generous support for individuals in need. Growing Demand for...

Continue Reading
Prelude Therapeutics and Incyte Join Forces for JAK2JH2 Inhibitor

Updated Category News Views 101

Prelude Therapeutics Partners with Incyte on JAK2V617F Program Incyte establishes exclusive option to acquire Prelude’s innovative programs These inhibitors have the potential to modify disease outcomes in patients with myeloproliferative neoplasms (MPNs) Prelude Therapeutics, a clinical-stage oncology company, has recently made headlines with an exciting announcement...

Continue Reading